InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Scholar Rock Holding Corp

SRRK Clue Score52
United States Fiscal year ends December CIK 0001727196 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
David Hallal
16 Apr 2026
Chief Executive Officer
Sell
30,615
$49.57
$1.52M
Vikas Sinha
16 Apr 2026
Chief Financial Officer
Sell
10,410
$49.57
$516.07K
Akshay Vaishnaw
16 Apr 2026
President of R&D
Sell
12,246
$49.57
$607.09K
Keith Woods
16 Apr 2026
Chief Operating Officer
Sell
10,220
$49.57
$506.65K
Mo Qatanani
17 Feb 2026
Chief Scientific Officer
Sell
7,989
$46.53
$371.71K
Caryn Parlavecchio
17 Feb 2026
CHRO
Sell
9,035
$46.53
$420.38K
Junlin Ho
17 Feb 2026
General Counsel
Sell
9,580
$46.53
$445.74K
Jing L. Marantz
17 Feb 2026
Chief Medical Officer
Sell
4,157
$46.53
$193.42K
Junlin Ho
16 Jan 2026
General Counsel
Sell
8,016
$44.48
$356.53K
Jing L. Marantz
16 Jan 2026
Chief Medical Officer
Sell
5,798
$44.48
$257.88K
Caryn Parlavecchio
16 Jan 2026
CHRO
Sell
6,600
$44.48
$293.55K
Mo Qatanani
16 Jan 2026
Chief Scientific Officer
Sell
8,406
$44.48
$373.88K
David Hallal
13 Jan 2026
Chief Executive Officer
Sell
57,450
$42.70
$2.45M
Akshay Vaishnaw
13 Jan 2026
President of R&D
Sell
20,438
$42.70
$872.70K
Keith Woods
13 Jan 2026
Chief Operating Officer
Sell
16,746
$42.70
$715.05K
Vikas Sinha
13 Jan 2026
Chief Financial Officer
Sell
16,755
$42.70
$715.44K
Show all 50 transactions →

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 2
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 3,410,382
History held since 31 May 2018